A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence
Status:
Active, not recruiting
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
Several lines of evidence suggest that classic hallucinogens such as psilocybin can
facilitate behavior change in addictions such as alcohol dependence. The proposed
investigation is a multi-site, double-blind active-controlled trial (n = 180, 90 per group)
contrasting the acute and persisting effects of psilocybin to those of diphenhydramine in the
context of outpatient alcoholism treatment.
Phase:
Phase 2
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health
Collaborators:
Heffter Research Institute University of New Mexico